startups digital health weight loss glp-1 Chasing the $100 Billion Market for Weight-Loss Drugs Long-term Success of GLP-1s Hinges

Their systemic anti-inflammatory effects, metabolic regulation, and influence on satiety and insulin sensitivity suggest they could help prevent the onset of multiple chronic conditions

High-dose prescribing by default Many vendors escalate members to the maximum dose, regardless of need

Presenter: Sophia Kenrick, Ph.D

To schedule an appointment with one of our certified Functional Medicine Physicians, please give us a call

These new drugs are reshaping not only how obesity is treated but also how it is perceived as a persistent medical condition stemming from biological factors, not merely a matter of self-discipline or resolve

FDA-approved compound that stimulates GH production